J. Wefel

Kyle R. Noll, J. Wefel, M. E. Bradshaw, 2018, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Preservation of Neurocognitive Function (NCF) with Conformal Avoidance of the Hippocampus during Whole-Brain Radiotherapy (HA-WBRT) for Brain Metastases: Preliminary Results of Phase III Trial NRG Oncology CC001

P. Brown, M. Mehta, W. Tomé, 2018, International Journal of Radiation Oncology*Biology*Physics.

Cognitive Changes in Cancer Survivors.

K. Krull, M. Janelsins, J. Wefel, 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Chemotherapy Versus Autologous Stem-Cell Transplantation for the Treatment of Transformed Follicular Lymphoma in the Rituximab Era

P. Brown, S. McGovern, J. Welsh, 2013 .

Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review.

J. Cata, J. Wefel, Ekin Guran, 2022, British journal of anaesthesia.

Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target

C. Meyers, J. Wefel, A. E. Kayl, 2004 .

Functional impact of androgen‐targeted therapy on patients with castration‐resistant prostate cancer

K. Winters-Stone, D. George, A. Morgans, 2022, BJUI compass.

Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors

A. Morgans, J. Jackson, C. Ryan, 2022, CNS Drugs.

Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.

Walter J Curran, Deborah T Blumenthal, Mark R Gilbert, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Therapies for Cognitive Deficits Associated with Chemotherapy for Breast Cancer: A Systematic Review of Objective Outcomes Morean DF, O'Dwyer L, Cherney LR (Northwestern Univ, Chicago, IL) Arch Phys Med Rehabil 96:1880-1897, 2015

Kyle R. Noll, J. Wefel, 2016 .

Comparative impact of treatment on patient reported outcomes (PROs) in patients with glioblastoma (GBM) enrolled in RTOG 0825.

D. Brachman, M. Gilbert, M. Mehta, 2013 .

Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiotherapy: The NRG Oncology/RTOG 0534 SPPORT Trial

D. Low, H. Sandler, É. Vigneault, 2018, International Journal of Radiation Oncology*Biology*Physics.

Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy

S. Kesler, R. O'Hara, Christa Watson, 2013, Brain Imaging and Behavior.

MP72-01 IMPROVEMENTS IN FREEDOM FROM PROGRESSION WITH SHORT TERM ANDROGEN DEPRIVATION THERAPY AND PELVIC LYMPH NODE TREATMENT ADDED TO PROSTATE BED SALVAGE RADIOTHERAPY: THE NRG ONCOLOGY/RTOG 0534 SPPORT TRIAL

D. Low, H. Sandler, J. Michalski, 2019, Journal of Urology.

Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions

J. Reijneveld, S. Deprez, M. Klein, 2014, EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.].

Neuropsychological Function and Quality of Life

J. Wefel, S. Kohli, Terri Armstrong, 2011 .

Cognitive Rehabilitation in Patients with Non-Central Nervous System Cancers and Brain Tumors

S. Kesler, K. Gehring, S. Schagen, 2020 .

Symptom Management for Patients with Brain Tumors: Improving Quality of Life

A. Burton, J. Wefel, P. Phan, 2007 .

Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism.

Jeffrey E. Lee, Douglas B. Evans, E. Jackson, 2009, Surgery.

Neuropsychological Sequelae of Non-Central Nervous System Cancer and Cancer Therapy

C. Meyers, J. Wefel, M. Witgert, 2008, Neuropsychology Review.

Genetic Modulation of Neurocognitive Function in Glioma Patients

M. Gilbert, S. Tsavachidis, E. Sulman, 2015, Clinical Cancer Research.

Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection.

Kyle R. Noll, D. Cahill, G. Rao, 2016, Neuro-oncology.

Clinical trial end points for high-grade glioma: the evolving landscape.

Timothy F Cloughesy, Mark R Gilbert, Wolfgang Wick, 2011, Neuro-oncology.

Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?

P. Brown, A. Asher, M. Ahluwalia, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.

P. Brown, M. Mehta, S. Bentzen, 2013, Neuro-oncology.

Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.

Joe Y. Chang, Edward S. Kim, P. Brown, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

‘Chemobrain’ in breast carcinoma?

R. Theriault, A. Buzdar, R. Lenzi, 2004, Cancer.

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.

P. Brown, M. Gilbert, M. Mehta, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.

M. Gilbert, L. Bidaut, E. Jackson, 2011, International journal of radiation oncology, biology, physics.

A review of prostate cancer treatment impact on the CNS and cognitive function

A. Morgans, C. Ryan, J. Wefel, 2019, Prostate Cancer and Prostatic Diseases.

A review of prostate cancer treatment impact on the CNS and cognitive function

A. Morgans, C. Ryan, J. Wefel, 2019, Prostate Cancer and Prostatic Diseases.

DaroACT: Darolutamide and enzalutamide effects on physical and neurocognitive function and daily activity in patients with castration-resistant prostate cancer (CRPC).

K. Winters-Stone, D. George, A. Morgans, 2020 .

International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

T. Ahles, S. Schagen, J. Vardy, 2011, The Lancet. Oncology.

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.

T. Mikkelsen, W. Yung, M. Prados, 2011, Neuro-oncology.

University of Groningen Cognitive Impairment in Men With Testicular Cancer Prior to Adjuvant Therapy

Salma K. Marani, H. Hoekstra, D. Vidrine, 2017 .

Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults

Kyle R. Noll, Shelli R Kesler, S. Kesler, 2015, CA: a cancer journal for clinicians.

Neuropsychological Assessment of Older Adults with a History of Cancer

J. Wefel, M. E. Bradshaw, M. Bradshaw, 2019, Handbook on the Neuropsychology of Aging and Dementia.

Neuropsychological assessment of adults with cancer

R. Collins, J. Wefel, A. E. Kayl, 2008 .

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

K. Hess, F. Lang, A. Shiu, 2009, The Lancet. Oncology.

Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012.

M. D. de Ruiter, B. Small, T. Ahles, 2015, Journal of pain and symptom management.

Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience

Kristin D. Alfaro, S. Khatua, K. Hess, 2021, Neuro-oncology advances.

A Prospective Phase II Randomized Trial of Proton Radiotherapy vs. Intensity Modulated Radiotherapy for Patients with Newly Diagnosed Glioblastoma.

Diane D. Liu, P. Brown, M. Gilbert, 2021, Neuro-oncology.

RADIATION THERAPY ONCOLOGY GROUP RTOG 0825 PHASE III DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF CONVENTIONAL CONCURRENT CHEMORADIATION AND ADJUVANT TEMOZOLOMIDE PLUS BEVACIZUMAB VERSUS CONVENTIONAL CONCURRENT CHEMORADIATION AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

K. Aldape, M. Mehta, H. Colman, 2009 .

ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases

N. Ibrahim, S. Kesari, M. Ahluwalia, 2020, Clinical Cancer Research.

Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

Eudocia Q Lee, Martin Bendszus, Gordon J Harris, 2018, The Lancet. Oncology.

A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.

M. Gilbert, K. Hess, H. Colman, 2008, Neuro-oncology.

Neurocognitive functioning and genetic variation in patients with primary brain tumours.

Kyle R. Noll, M. Scheurer, J. Wefel, 2016, The Lancet. Oncology.

Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism.

Jeffrey E. Lee, Douglas B. Evans, E. Mittendorf, 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

W. Curran, M. Gilbert, M. Macsai, 2022, Neuro-oncology.

Neurocognitive Function in Adult Cancer Patients.

J. Wefel, R. Harrison, 2018, Neurologic clinics.

Stereotactic Radiosurgery versus Whole-brain Radiation Therapy for Patients with 4-15 Brain Metastases: A Phase III Randomized Controlled Trial

Diane D. Liu, P. Brown, S. McGovern, 2020 .

Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.

Susan M. Chang, P. Brown, M. Mehta, 2013, The Lancet. Oncology.

Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.

Susan M. Chang, P. Brown, M. Mehta, 2013, The Lancet. Oncology.

Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.

Maria Werner-Wasik, Tito R Mendoza, Corneel Coens, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neurocognitive Effects of Brain Metastases and Their Treatment

C. Chung, J. Wefel, K. Feghali, 2020 .

Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes

W. Curran, D. Brachman, P. Brown, 2019, Neurosurgery.

Erratum: Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system (International Journal of Radiation Oncology Biology Physics (2011) 79:5 (1487-95) DOI: 10.1016/j.ijrobp.2009.12.061)

M. Gilbert, L. Bidaut, E. Jackson, 2012 .

Neurocognitive Toxicity from Radiation Therapy for Brain Metastases

C. Chung, J. Wefel, K. Feghali, 2019, Central Nervous System Metastases.

A PILOT STUDY OF NEUROCOGNITIVE FUNCTION IN PATIENTS WITH ONE TO THREE NEW BRAIN METASTASES INITIALLY TREATED WITH STEREOTACTIC RADIOSURGERY ALONE

S. Hassenbusch, F. Lang, A. Shiu, 2007, Neurosurgery.

OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 110 ( 28 ) ISSN 0027-8424

Fumiko Hoeft, S M Hadi Hosseini, Shelli R Kesler, 2013 .

Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors.

Kyle R. Noll, M. Taphoorn, L. Dirven, 2021, Hematology/oncology clinics of North America.

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

A. Buzdar, C. Meyers, J. Wefel, 2010, Cancer.

Functional Outcomes and Health-Related Quality of Life Following Glioma Surgery

M. Berger, P. C. de Witt Hamer, M. Klein, 2021, Neurosurgery.

Interventions for the management of fatigue in adults with a primary brain tumour.

L. Katz, J. Wefel, J. Day, 2016, The Cochrane database of systematic reviews.

Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?

S. Schagen, A. Compter, J. Wefel, 2022, Nature Reviews Neurology.

CODEL: Phase III study of RT, RT + Temozolomide (TMZ), or TMZ for newly-diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the initial study design.

K. Aldape, P. Brown, M. J. van den Bent, 2020, Neuro-oncology.

Cognitive function and patient‐reported memory problems after radiotherapy for cancers at the skull base: A cross‐sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory‐Head and Neck Module

Jason M. Johnson, A. Garden, C. Fuller, 2017, Head & neck.

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

Susan M. Chang, P. Brown, M. Mehta, 2018, The Lancet. Oncology.

Congruence of primary brain tumor patient and caregiver symptom report

M. Gilbert, C. Cleeland, T. Mendoza, 2012, Cancer.

Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma.

B. O'neill, C. Meyers, J. Wefel, 2012, Neuro-oncology.

Preservation of neurocognitive function in the treatment of brain metastases

M. Parsons, J. Wefel, K. Peters, 2021, Neuro-oncology Advances.

Monitoring of Neurocognitive Function in the Care of Patients with Brain Tumors

Kyle R. Noll, M. Parsons, J. Wefel, 2019, Current Treatment Options in Neurology.

Interventions for cognitive problems in adults with brain cancer: A narrative review

M. Sitskoorn, K. Gehring, S. Schagen, 2019, European journal of cancer care.

Impaired neurocognitive function in glioma patients: from pathophysiology to novel intervention strategies

Kyle R. Noll, J. Wefel, T. Walbert, 2020, Current opinion in neurology.

Neurocognitive function before and after surgery for insular gliomas.

F. Lang, B. Bekele, Lianchun Xiao, 2011, Journal of neurosurgery.

Sanne B. Schagen, S. Schagen, J. Wefel, 2012, Current Neurology and Neuroscience Reports.

Relationship between cognitive function and prognosis in glioblastoma.

J. Wefel, D. Johnson, 2013, CNS oncology.

Systemically Treated Breast Cancer Patients and Controls: An Evaluation of the Presence of Noncredible Performance

S. Schagen, J. Wefel, Rozemarijn L Kornet, 2014, Journal of the International Neuropsychological Society.

Memory performance after head injury: contributions of malingering, litigation status, psychological factors, and medication use.

D. Tranel, J. Suhr, J. Barrash, 1997, Journal of clinical and experimental neuropsychology.

Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design.

Katherine A Myszka, R. Champlin, Melissa A. Friedman, 2009, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy

J. Benge, P. Massman, N. Perrier, 2009, Journal of the International Neuropsychological Society.

The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma

R. Theriault, R. Lenzi, C. Meyers, 2004, Cancer.

Relationship Between Neuropsychological Test Performance and Productivity at 1-Year Following Traumatic Brain Injury

T. Novack, C. Contant, T. Roebuck, 2004, The Clinical neuropsychologist.

Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy

S. Kesler, A. Sood, L. Mangala, 2018, Molecular and Cellular Neuroscience.

Association of genetic variants with fatigue in patients with malignant glioma.

M. Gilbert, G. Breton, M. Bondy, 2018, Neuro-oncology practice.

Neurocognitive, Symptom, and Health- Related Quality of Life Outcomes of a Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma (NRG/RTOG 0825).

D. Brachman, P. Brown, M. Gilbert, 2021, Neuro-oncology.

Depressive symptoms and executive function in relation to survival in patients with glioblastoma

Kyle R. Noll, J. Wefel, C. Sullaway, 2019, Journal of Neuro-Oncology.

Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma

Kyle R. Noll, J. Weinberg, J. Wefel, 2017, Psycho-oncology.

Neurocognitive aspects of brain metastasis.

P. Brown, M. Parsons, J. Wefel, 2018, Handbook of clinical neurology.

Neurocognitive functioning is associated with functional independence in newly diagnosed patients with temporal lobe glioma.

Kyle R. Noll, J. Weinberg, J. Wefel, 2018, Neuro-oncology practice.

RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).

Robert Jeraj, Maria Werner-Wasik, Deborah T Blumenthal, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NRG Oncology CC001: A phase III trial of hippocampal avoidance (HA) in addition to whole-brain radiotherapy (WBRT) plus memantine to preserve neurocognitive function (NCF) in patients with brain metastases (BM).

P. Brown, M. Mehta, W. Tomé, 2019, Journal of Clinical Oncology.

NRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole-Brain Radiotherapy (WBRT) Plus Memantine to Preserve Neurocognitive Function (NCF) in Patients With Brain Metastases (BM)

P. Brown, M. Mehta, W. Tomé, 2019, Neurosurgery.

Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving Whole-brain Radiation Therapy (WBRT): First Report of RTOG 0614, a Placebo-controlled, Double-blind, Randomized Trial

P. Brown, M. Mehta, V. Kavadi, 2012 .

CTNI-29. CODEL: PHASE III TRIAL OF RT ALONE, RT PLUS TMZ, OR TMZ ALONE FOR NEWLY-DIAGNOSED, 1p/19q CODELETED ANAPLASTIC OLIGODENDROGLIOMA. ANALYSIS FROM THE INITIAL STUDY DESIGN. (NCCTG N0577, ALLIANCE)

K. Aldape, P. Brown, M. Weller, 2020 .

Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons

Yuri Dabaghian, S. Kesler, Y. Dabaghian, 2016, Scientific Reports.

Complications of radiation and chemotherapy Radiation therapy Acute reactions Cerebral edema Headaches Nausea Encephalopathy Early – delayed reactions Encephalopathy Cognitive dysfunction Myelopathy Endocrine dysfunction Vasculopathy Late – delayed reactions Cognitive dysfunction Dementia Necrosis L

M. Monje, J. Dietrich, J. Wefel, 2008 .

Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients

S. Tsavachidis, E. Sulman, M. Bondy, 2021, Journal of Neuro-Oncology.

The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy.

P. Brown, D. Bruner, S. Pugh, 2018, Neuro-oncology practice.

A prospective study of cognitive function in men with non‐seminomatous germ cell tumors

Salma K. Marani, H. Hoekstra, D. Vidrine, 2014, Psycho-oncology.

Neuropsychological functioning in depressed versus nondepressed participants with Alzheimer's disease.

J. Wefel, B. Hoyt, J S Wefel, 1999, The Clinical neuropsychologist.

Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant

C. Cleeland, X. Wang, J. Wefel, 2013, Cancer.

A Technique for Mapping Cortical Areas Associated with Speech Arrest

G. Rao, S. Prabhu, J. Wefel, 2012, Stereotactic and Functional Neurosurgery.

Reply to v.R. Bhatt et Al and m.C. Chamberlain.

P. Brown, S. McGovern, J. Welsh, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor

R. Collins, K. Gehring, C. Meyers, 2012, Journal of Neuro-Oncology.

Cognitive complaints after breast cancer treatments: Examining the relationship with neuropsychological test performance

S. Schagen, J. Wefel, 2014 .

Validation of Non-invasive Language Mapping Modalities for Eloquent Tumor Resection: A Pilot Study

Kyle R. Noll, Ho-Ling Liu, S. Prabhu, 2022, Frontiers in Neuroscience.

S. Schagen, J. Wefel, 2013, EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.].

Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms with Hippocampal Avoidance during Whole-Brain Radiotherapy for Brain Metastases: Final Results of NRG Oncology CC001.

P. Brown, M. Gilbert, M. Mehta, 2023, International Journal of Radiation Oncology, Biology, Physics.

NEURO/MEDICAL ONCOLOGY

Scott N. Hwang, Katrina H. Smith, Susan M. Chang, 2013 .

Neuropsychology in the Neurosurgical Management of Primary Brain Tumors

Kyle R. Noll, S. Prabhu, D. Sabsevitz, 2019, Neurosurgical Neuropsychology.

Cancer as a risk factor for dementia: a house built on shifting sand.

C. Meyers, J. Wefel, 2005, Journal of the National Cancer Institute.

The neuropsychology of oncology.

J. Wefel, M. E. Bradshaw, 2014 .

TBCRC 022: Phase II trial of neratinib for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer and brain metastases (BCBM).

E. Winer, Minetta C. Liu, N. Ibrahim, 2014 .